Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Surg Res. 2014 May 21;190(2):548–553. doi: 10.1016/j.jss.2014.05.031

Table 2.

Somatostatin analogue uptake detected on the SRS reports for various abdominal locations.

Primary tumor Mesenteric adenopathy Liver metastases No uptake
Localizing (n = 13) 13 3 (23%) 9 (69%) NA
Non-localizing (n = 24) NA 10 (42%) 17 (71%) 3 (13%)
p-value ----- 0.44 1 -----

P-value < 0.05 is considered significant.